Reativação sanguínea do citomegalovírus em pacientes críticos com COVID-19: fatores de risco e impacto sobre a mortalidade.
23 Mai, 2022 | 13:29h
Comentário no Twitter
CMV reactivation in #COVID19 critically ill pts:
🦠frequent! >20% in this study
🧪risk depends on severity of illness/occurrence of secondary bacterial infections in #ICU
🏥 prolonged hospital stay & higher mortality but independent association lacking.
📎 https://t.co/N8JVD1GyPQ pic.twitter.com/KYRtLmxtJg— Intensive Care Medicine (@yourICM) May 18, 2022